Direkt zum Seiteninhalt, zur Hauptnavigation, zur Unternavigation, zur Fußzeile.

20 September 2010

Updated survival data from IMA901 Phase II study will be presented at the 35th ESMO Congress in Milan (October 8-12)

The IMA901 Phase II abstract was selected by ESMO for poster discussion and updated survival data will be presented on:
 
October 11th, 2010 (Poster discussion will be held from 12:30 PM - 13:30 PM in Halls Orange 2+3)
 
Session Genitourinary Tumors
 
Survival update of a randomized Phase 2 study (IMA901-202) investigating therapeutic vaccination with multiple tumor-associated peptides (TUMAP) in renal cell carcinoma (RCC) patients after failure of previous therapy with cytokines or kinase inhibitors
(Poster presentation session, Abstract ID 875PD)
 
We are looking forward to meeting you there!
 
www.esmo.org/events/milan-2010-congress.html
 
Poster is now available for download here!